Rat models of type 1 diabetes: Genetics, environment, and autoimmunity

Animal Models of Diabetes, Second Edition: Frontiers in Research

Volumn , Issue , 2007, Pages 1-39

  Mordes, John P ^a   Poussier, Philippe ^b   Rossini, Aldo A ^a   Blankenhorn, Elizabeth P ^c   Greiner, Dale L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80755123995     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (281)

1. Åkerblom HK, Vaarala O, Hyöty H, et al. (2002) Environmental factors in the etiology of T1D. Am J Med Genet 115:18-29.
2. Alexopoulou L, Holt AC, Medzhitov R, et al. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
3. Allen HF, Klingensmith GJ, Jensen P, et al. (1999) Effect of bacillus Calmette-Guerin vaccination on new-onset T1D-A randomized clinical study. Diabetes Care 22:1703-1707.
4. American Diabetes Association. (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29 (Suppl. 1):S43-S48.
5. Anderson MS, Bluestone JA. (2005) The NOD mouse: A model of immune dysregulation. Annu Rev Immunol 23:447-485.
6. Atkinson M, Leiter EH. (1999) The NOD mouse model of insulin dependent diabetes: As good as it gets? Nat Med 5:601-604.
7. Atkinson MA, Eisenbarth GS. (2001) T1D: New perspectives on disease pathogenesis and treatment. Lancet 358:221-229.
8. Atkinson MA, Maclaren NK, Luchetta R. (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937.
9. Awata T, Guberski DL, Like AA. (1995) Genetics of the BB rat: Association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II. Endocrinology 136:5731-5735.
10. Bach JF. (2002) Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911-920.
11. Battan R, Mordes JP, Abreau S, et al. (1994) Evidence that intrathymic islet transplantation does not prevent diabetes or subsequent islet graft destruction in RT6- depleted diabetes resistant BioBreeding/Worcester rats. Transplantation 57:731-736.
12. Beam HA, Parsons JR, Lin SS. (2002) The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 20:1210-1216.
13. Beaudette-Zlatanova BC, Whalen B, Zipris D, et al. (2006) Costimulation and autoimmune diabetes in BB rats. Am J Transplant 6:894-902.
14. Bellmann K, Kolb H, Rastegar S, et al. (1998) Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats. Diabetologia 41:844-847.
15. Bergholdt R, Taxvig C, Eising S, et al. (2005) CBLB variants in T1D and their genetic interaction with CTLA4. J Leukocyte Biol 77:579-585.
16. Bertrand S, Vigeant C, Yale J-F. (1994) Predictive value of lymphocyte antibodies for the appearance of diabetes in BB rats. Diabetes 43:137-142.
17. Bieg S, Möller C, Olsson T, et al. (1997) The lymphopenia (lyp) gene controls the intrathymic cytokine ratio in congenic BioBreeding rats. Diabetologia 40:786-792.
18. Blanas E, Carbone FR, Allison J, et al. (1996) Induction of autoimmune diabetes by oral administration of autoantigen. Science 274:1707-1709.
19. Blankenhorn EP, Rodemich L, Martin-Fernandez C, et al. (2005) The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection. Diabetes 54:1233-1237.
20. Blomqvist M, Kaas A, Mansson JE, et al. (2003) Developmental expression of the type I diabetes related antigen sulfatide and sulfated lactosylceramide in mammalian pancreas. J Cell Biochem 89:301-310.
21. Bortell R, Kanaitsuka T, Stevens LA, et al. (1999) The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse. Mol Cell Biochem 193:61-68.
22. Bortell R, Waite DJ, Whalen BJ, et al. (2001) Levels of Art2+ cells but not soluble Art2 protein correlate with expression of autoimmune diabetes in the BB rat. Autoimmunity 33:199-211.
23. Broderick TL, Hutchison AK. (2004) Cardiac dysfunction in the euglycemic diabetic-prone BB Wor rat. Metabolism 53:1391-1394.
24. Brown DW, Welsh RM, Like AA. (1993) Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol 67:5873-5878.
25. Brugman S, Klatter FA, Visser J, et al. (2004) Neonatal oral administration of DiaPep277, combined with hydrolyzed casein diet, protects against T1D in BB-DP rats. An experimental study. Diabetologia 47:1331-1333.
26. Burstein D, Handler ES, Schindler J, et al. (1987) Effect of interleukin-2 on diabetes in the BB/Wor rat. Diabetes Res 5:163-167.
27. Burstein D, Mordes JP, Greiner DL, et al. (1989) Prevention of diabetes in the BB/Wor rat by a single transfusion of spleen cells: Parameters that affect the degree of protection. Diabetes 38:24-30.
28. Buschard K, Blomqvist M, Osterbye T, et al. (2005) Involvement of sulfatide in beta cells and type 1 and type 2 diabetes. Diabetologia 48:1957-1962.
29. Butler L, Guberski DL, Like AA. (1991) Changes in penetrance and onset of spontaneous diabetes in the BB/Wor rat. In Lessons from animal diabetes III, ed. Shafrir E. London: Smith-Gordon, 50-53.
30. Carlson EC, Vari RC, Audette JL, et al. (2004) Significant glomerular basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone BB Wistar rats. Anat Rec 281A:1308-1318.
31. Carreno BM, Collins M. (2002) The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20:29-53.
32. Chaillous L, Lefèvre H, Thivolet C, et al. (2000) Oral insulin administration and residual bcell function in recent-onset T1D: A multicentre randomized controlled trial. Diabetes Insulin Orale Group. Lancet 356:545-549.
33. Chao NJ, Timmerman L, McDevitt HO, et al. (1989) Molecular characterization of MHC class II antigens (beta 1 domain) in the BB diabetes-prone and -resistant rat. Immunogenetics 29:231-234.
34. Chen S, Howard O. (2004) Parvovirus B19 infection. N Engl J Med 350:598.
35. Chung YH, Jun HS, Kang Y, et al. (1997) Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus induced autoimmune diabetes in diabetes-resistant biobreeding rats. J Immunol 159:466-471.
36. Chung YH, Jun HS, Son M, et al. (2000) Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 165:2866-2876.
37. Colle E. (1990) Genetic susceptibility to the development of spontaneous insulin-dependent diabetes mellitus in the rat. Clin Immunol Immunopathol 57:1-9.
38. Colle E, Fuks A, Poussier P, et al. (1992) Polygenic nature of spontaneous diabetes in the rat: Permissive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility. Diabetes 41:1617-1623.
39. Colle E, Guttmann RD, Fuks A, et al. (1986) Genetics of the spontaneous diabetic syndrome. Interaction of MHC and non-MHC-associated factors. Mol Biol Med 3:13-23.
40. Colzani RM, Alex S, Dunn AD, et al. (1999) The oral administration of human thyroglobulin does not affect the incidence of lymphocytic thyroiditis in the BioBreeding Worcester rat. Thyroid 9:831-835.
41. Corper AL, Stratmann T, Apostolopoulos V, et al. (2000) A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288:505-511.
42. Couper JJ, Steele C, Beresford S, et al. (1999) Lack of association between duration of breastfeeding or introduction of cow’s milk and development of islet autoimmunity. Diabetes 48:2145-2149.
43. Courtois P, Nsimba G, Jijakli H, et al. (2005) Gut permeability and intestinal mucins, invertase, and peroxidase in control and diabetes-prone BB rats fed either a protective or a diabetogenic diet. Dig Dis Sci 50:266-275.
44. Cremer MA, Ye XJ, Myers LK, et al. (2004) T cell immunity to type II collagen in the biobreeding rat: The identification and characterization of RT1u-restricted T cell epitopes on a1(II). J Immunol 173:1795-1801.
45. Crisá L, Mordes JP, Rossini AA. (1992) Autoimmune diabetes mellitus in the BB rat. Diabetes/Metab Rev 8:9-37.
46. Davenport C, Lovell H, James RFL, et al. (1995) Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase. Clin Exp Immunol 101:127-135.
47. De Filippo G, Carel JC, Boitard C, et al. (1996) Long-term results of early cyclosporin therapy in juvenile IDDM. Diabetes 45:101-104.
48. DeSilva MG, Jun HS, Yoon JW, et al. (1996) Autoantibodies to IA-2 not detected in NOD mice or BB rats. Diabetologia 39:1237-1238.
49. Diessenbacher P, Bartels K, Koch-Nolte F, et al. (2003) T-cell survival regulator LKLF is not involved in inappropriate apoptosis of diabetes-prone BBDP rat T cells. Ann NY Acad Sci 1010:548-551.
50. Doukas J, Cutler AH, Mordes JP. (1994) Polyinosinic:polycytidylic acid is a potent activator of endothelial cells. Am J Pathol 145:137-147.
51. Doukas J, Majno G, Mordes JP. (1996) Antiendothelial cell autoantibodies in BB rats with spontaneous and induced IDDM. Diabetes 45:1209-1216.
52. Dugoni WE Jr., Bartlett ST. (1990) Evidence that cyclosporine prevents rejection and recurrent diabetes in pancreatic transplants in the BB rat. Transplantation 49:845-848.
53. Dyrberg T, Schwimmbeck PL, Oldstone MBA. (1988) Inhibition of diabetes in BB rats by virus infection. J Clin Invest 81:928-931.
54. Earle KE, Tang Q, Zhou X, et al. (2005) In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 115:3-9.
55. Elder ME, Maclaren NK. (1983) Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol 130:1723-1731.
56. Elias D, Marcus H, Reshef T, et al. (1995) Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein. Eur J Immunol 25:2851-2857.
57. Ellerman KE, Like AA. (2000) Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 43:890-898.
58. Ellerman KE, Richards CA, Guberski DL, et al. (1996) Kilham rat virus triggers T-celldependent autoimmune diabetes in multiple strains of rat. Diabetes 45:557-562.
59. Elliott RB, Martin JM. (1984) Dietary protein: A trigger of insulin dependent diabetes in the BB rat? Diabetologia 26:297-299.
60. Elliott RB, Pilcher CC, Stewart A, et al. (1993) The use of nicotinamide in the prevention of T1D. Ann NY Acad Sci 696:333-341.
61. Ellis EA, Guberski DL, Hutson B, et al. (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6:295-304.
62. England WL, Roberts SD. (1981) Immunization to prevent insulin-dependent diabetes mellitus? The economics of genetic screening and vaccination for diabetes. Ann Int Med 94:395-400.
63. Ewel CH, Sobel DO, Zeligs BJ, et al. (1992) Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41:1016-1021.
64. Feutren G, Mihatsch MJ. (1992) Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660.
65. Filippi C, Von Herrath M. (2005) How viral infections affect the autoimmune process leading to T1D. Cell Immunol 233:125-132.
66. Follak N, Klöting I, Merk H. (2005) Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diab/Metab Res Rev 21:288-296.
67. Fuks A, Ono SJ, Colle E, et al. (1990) A single dose of the MHC-linked susceptibility determinant associated with the RT1u haplotype is permissive of insulin-dependent diabetes mellitus in the BB rat. Expl Clin Immunogenet 7:162-169.
68. Geenen V, Brilot F. (2003) Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system. Ann NY Acad Sci 992:186-195.
69. Georgiou HM, Bellgrau D. (1989) Thymus transplantation and disease prevention in the diabetes-prone BioBreeding rat. J Immunol 142:3400-3405.
70. Georgiou HM, Lagarde AC, Bellgrau D. (1988) T cell dysfunction in the diabetes-prone BB rat. A role for thymic migrants that are not T cell precursors. J Exp Med 167:132-148.
71. Gerling IC, Friedman H, Greiner DL, et al. (1994) Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes 43:433-440.
72. Gold DP, Bellgrau D. (1991) Identification of a limited T-cell receptor ß chain variable region repertoire associated with diabetes in the BB rat. Proc Natl Acad Sci USA 88:9888-9891.
73. Gotfredsen CF, Buschard K, Frandsen EK. (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28:933-935.
74. Gottlieb PA, Handler ES, Appel MC, et al. (1991) Insulin treatment prevents diabetes in RT6- depleted diabetes resistant BB/Wor rats. Diabetologia 34:296-300.
75. Graham S, Courtois P, Malaisse WJ, et al. (2004) Enteropathy precedes T1D in the BB rat. Gut 53:1437-1444.
76. Green A, Patterson CC, Eurodiab Tiger Study Group. (2001) Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44:B3-B8.
77. Greiner DL, Handler ES, Nakano K, et al. (1986) Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 136:148-151.
78. Greiner DL, Mordes JP, Handler ES, et al. (1987) Depletion of RT6.1+ T lymphocytes induces diabetes in resistant BioBreeding/Worcester (BB/W) rats. J Exp Med 166:461-475.
79. Greiner DL, Rossini AA, Mordes JP. (2001) Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: Caveat emptor and primum non nocere. Clin Immunol 100:134-143.
80. Guberski DL. (1994) Diabetes-prone and diabetes-resistant BB rats: Animal models of spontaneous and virally induced diabetes mellitus, lymphocytic thyroiditis, and collageninduced arthritis. ILAR News 35:29-37.
81. Guberski DL, Thomas VA, Shek WR, et al. (1991) Induction of T1D by Kilham’s rat virus in diabetes resistant BB/Wor rats. Science 254:1010-1013.
82. Gunther E, Walter L. (2001) The major histocompatibility complex of the rat (Rattus norvegicus). Immunogenetics 53:520-542.
83. Handler ES, Mordes JP, McKeever U, et al. (1989) Effects of irradiation on diabetes in the BB/Wor rat. Autoimmunity 4:21-30.
84. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, et al. (1989) Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia 32:126-134.
85. Hardin JA, Donegan L, Woodman RC, et al. (2002) Mucosal inflammation in a genetic model of spontaneous type I diabetes mellitus. Can J Physiol Pharmacol 80:1064-1070.
86. Hawa MI, Beyan H, Buckley LR, et al. (2002) Impact of genetic and non-genetic factors in T1D. Am J Med Genet 115:8-17.
87. Helgason T, Jonasson MR. (1981) Evidence for a food additive as a cause of ketosis-prone diabetes. Lancet 2:716-720.
88. Hermitte L, Vialettes B, Atlef N, et al. (1989) High-dose nicotinamide fails to prevent diabetes in BB rats. Autoimmunity 5:79-86.
89. Hessner M, Wang X, Ghosh S. (2004) Genetics of T1D. In Diabetes mellitus. A fundamental and clinical text, ed. LeRoith D, Taylor SI, Olefsky JM. New York: Lippincott, 483-498.
90. Hessner MJ, Wang XJ, Meyer L, et al. (2004) Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of T1D mellitus in the BioBreeding rat. J Immunol 173:6993-7002.
91. Hiemstra HS, Schloot NC, Van Veelen PA, et al. (2001) Cytomegalovirus in autoimmunity: T cell cross-reactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 98:3988-3991.
92. Hillebrands JL, van der Werf N, Klatter FA, et al. (2003) Role of peritoneal macrophages in cytomegalovirus-induced acceleration of autoimmune diabetes in BB-rats. Clin Develop Immunol 10:133-139.
93. Höglund P, Mintern J, Waltzinger C, et al. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331-339.
94. Hornum L, DeScipio C, Markholst H, et al. (2004) Comparative mapping of rat Iddm4 to segments on HSA7 and MMU6. Mamm Genome 15:53-61.
95. Hornum L, Lundsgaard D, Markholst H. (2001) An F344 rat congenic for BB/DP ratderived diabetes susceptibility loci Iddm1 and Iddm2. Mamm Genome 12:867-868.
96. Hornum L, Rømer J, Markholst H. (2002) The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of iddm1. Diabetes 51:1972-1979.
97. Hviid A, Stellfeld M, Wohlfahrt J, et al. (2004) Childhood vaccination and T1D. N Engl J Med 350:1398-1404.
98. Inkinen K, Soots A, Krogerus L, et al. (2005) Cytomegalovirus enhance expression of growth factors during the development of chronic allograft nephropathy in rats. Transplant Int 18:743-749.
99. Iovino G, Kubow S, Marliss EB. (1999) Effect of a-phenyl-N-tert-butylnitrone on diabetes and lipid peroxidation in BB rats. Can J Physiol Pharmacol 77:166-174.
100. Iwakoshi NN, Goldschneider I, Tausche F, et al. (1998) High-frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone BioBreeding rats. J Immunol 160:5838-5850.
101. Jackson R, Kadison P, Buse J, et al. (1983) Lymphocyte abnormalities in the BB rat. Metabolism 32 (Suppl. 1):83-86.
102. Jackson R, Rassi N, Crump T, et al. (1981) The BB diabetic rat: profound T-cell lymphocytopenia. Diabetes 30:887-889.
103. Jacob HJ, Pettersson A, Wilson D, et al. (1992) Genetic dissection of autoimmune type I diabetes in the BB rat. Nat Genet 2:56-60.
104. Jiang Z, Handler ES, Rossini AA, et al. (1990) Immunopathology of diabetes in the RT6- depleted diabetes-resistant BB/Wor rat. Am J Pathol 137:767-777.
105. Jörns A, Gunther A, Hedrich HJ, et al. (2005) Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of T1D in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54:2041-2052.
106. Jörns A, Kubat B, Tiedge M, et al. (2004) Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm-iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch Int J Pathol 444:183-189.
107. Joseph S, Diamond AG, Smith W, et al. (1993) BB-DR/Edinburgh: A lymphopenic, nondiabetic subline of BB rats. Immunology 78:318-328.
108. Kamiya H, Murakawa Y, Zhang W, et al. (2005) Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diabetes/Metab Res Rev 21:448-458.
109. Kawano K, Hirashima T, Mori S, et al. (1991) New inbred strain of Long-Evans Tokushima lean rats with IDDM without lymphopenia. Diabetes 40:1375-1381.
110. Kecha-Kamoun O, Achour I, Martens H, et al. (2001) Thymic expression of insulin-related genes in an animal model of autoimmune T1D. Diabetes/Metab Res Rev 17:146-152.
111. Kimpimäki T, Erkkola M, Korhonen S, et al. (2001) Short-term exclusive breastfeeding predisposes young children with increased genetic risk of type I diabetes to progressive beta-cell autoimmunity. Diabetologia 44:63-69.
112. Klöting N, Klöting I. (2004) Congenic mapping of T1D-protective gene(s) in an interval of Mb on rat chromosome 6q32. Biochem Biophys Res Commun 323:388-394.
113. Klöting I, Kovacs P. (1998a) Genes of the immune system cosegregate with the age at onset of diabetes in the BB/OK rat. Biochem Biophys Res Commun 242:460-463.
114. Klöting I, Kovacs P. (1998b) Phenotypic differences between diabetes-prone BB rat sublines cosegregate with loci on chromosomes X and 10. Biochem Mol Biol Int 45:865-870.
115. Klöting I, Schmidt S, Kovacs P. (1998) Mapping of novel genes predisposing or protecting diabetes development in the BB/OK rat. Biochem Biophys Res Commun 245:483-486.
116. Klöting I, Van den Brandt J, Kuttler B. (2001) Genes of SHR rats protect spontaneously diabetic BB/OK rats from diabetes: Lessons from congenic BB.SHR rat strains. Biochem Biophys Res Commun 283:399-405.
117. Klöting N, Wilke B, Klöting I. (2004) Phenotypic and genetic analyses of subcongenic BB.SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome. Physiol Genomics 18:325-330.
118. Klöting N, Wilke B, Klöting I. (2005) Alleles on rat chromosome 4 (D4Got41-Fabp1/Tacr1) regulate subphenotypes of obesity. Obesity Res 13:589-595.
119. Kolb H, Wörz-Pagenstert U, Kleemann R, et al. (1996) Cytokine gene expression in the BB rat pancreas: Natural course and impact of bacterial vaccines. Diabetologia 39:1448-1454.
120. Komeda K, Noda M, Terao K, et al. (1998) Establishment of two substrains, diabetes-prone and nondiabetic, from Long-Evans Tokushima lean (LETL) rats. Endocrinology J 45:737-744.
121. Kovács P, Van den Brandt J, Bonné ACM, et al. (2001) Congenic BB.SHR rat provides evidence for effects of a chromosome 4 segment (D4Mit6-Npy similar to 1 cm) on total serum and lipoprotein lipid concentration and composition after feeding a highfat, high-cholesterol diet. Metabolism 50:458-462.
122. Kover KL, Geng ZH, Hess DM, et al. (2000) Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes 49:1666-1670.
123. Kuttler B, Steveling A, Klöting N, et al. (2003) Aminoguanidine downregulates expression of cytokine-induced Fas and inducible nitric oxide synthase but not cytokineenhanced surface antigens of rat islet cells. Biochem Pharmacol 66:2437-2448.
124. Kwan CY. (1999) Membrane abnormalities of vascular smooth muscle of mesenteric arteries of spontaneous diabetic BB rats. J Smooth Muscle Res 35:77-86.
125. Kyvik KO, Green A, Beck-Nielsen H. (1995) Concordance rates of insulin dependent diabetes mellitus: A population-based study of young Danish twins. Br Medical J 311:913-917.
126. Lampeter EF, Klinghammer A, Scherbaum WA, et al. (1998) The Deutsche Nicotinamide Intervention Study-An attempt to prevent T1D. Diabetes 47:980-984.
127. Lam-Tse WK, Lernmark Å, Drexhage HA. (2002) Animal models of endocrine/organ-specific autoimmune diseases: Do they really help us to understand human autoimmunity? Springer Semin Immunopathol 24:297-321.
128. Lang J, Bellgrau D. (2002) A T-cell functional phenotype common among autoimmune-prone rodent strains. Scand J Immunol 55:546-559.
129. Laron Z. (2002) Interplay between heredity and environment in the recent explosion of type childhood diabetes mellitus. Am J Med Genet 115:4-7.
130. Larsen B, Liu HG, Jackman S, et al. (2000) Effect of gliotoxin on development of diabetes mellitus in diabetes-prone BB/Wor rats. Ann Clin Lab Sci 30:99-106.
131. Laupacis A, Stiller CR, Gardell C, et al. (1983) Cyclosporin prevents diabetes in BB Wistar rats. Lancet 1:10-12.
132. Lefkowith J, Schreiner G, Cormier J, et al. (1990) Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes. J Exp Med 171:729-743.
133. Leiter EH, Von Herrath M. (2004) Animal models have little to teach us about T1D: 2. In opposition to this proposal. Diabetologia 47:1657-1660.
134. Lenzen S, Tiedge M, Elsner M, et al. (2001) The LEW.1AR1/Ztm-iddm rat: A new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 44:1189-1196.
135. Li DD, Gál I, Vermes C, et al. (2004) Cutting edge: Cbl-b: One of the key molecules tuning CD28- and CTLA-4-Mediated T cell costimulation. J Immunol 173:7135-7139.
136. Li XB, Scott FW, Park YH, et al. (1995) Low incidence of autoimmune type I diabetes in BB rats fed a hydrolyzed casein-based diet associated with early inhibition of nonmacrophage- dependent hyperexpression of MHC class I molecules on beta cells. Diabetologia 38:1138-1147.
137. Li ZG, Zhang W, Grunberger G, et al. (2002) Hippocampal neuronal apoptosis in T1D. Brain Res 946:221-231.
138. Like AA, Anthony M, Guberski DL, et al. (1983) Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes. Diabetes 32:326-330.
139. Like AA, Appel MC, Rossini AA. (1982) Autoantibodies in the BB/W rat. Diabetes 31:816-820.
140. Like AA, Weringer EJ, Holdash A, et al. (1985) Adoptive transfer of autoimmune diabetes in BioBreeding/Worcester (BB/W) inbred and hybrid rats. J Immunol 134:1583-1587.
141. Liu HG, Jackman S, Driscoll H, et al. (2000) Immunologic effects of gliotoxin in rats: Mechanisms for prevention of autoimmune diabetes. Ann Clin Lab Sci 30:366-378.
142. Lucke S, Klöting I, Pusch A, et al. (2003) Endocrine pancreas histology of congenic BB-rat strains with reduced diabetes incidence after genetic manipulation on chromosomes 4, 6 and X. Autoimmunity 36:143-149.
143. Lundsgaard D, Holm TL, Hornum L, et al. (2005) In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3. Diabetes 54:1040-1047.
144. MacFarlane AJ, Burghardt KM, Kelly J, et al. (2003) A T1D-related protein from wheat (Triticum aestivum)-cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. J Biol Chem 278:54-63.
145. Mackay IR, Bone A, Tuomi T, et al. (1996) Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus. J Autoimmunity 9:705-711.
146. MacMurray AJ, Moralejo DH, Kwitek AE, et al. (2002) Lymphopenia in the BB rat model of T1D is due to a mutation in a novel immune-associated nucleotide (lan)-related gene. Genome Res 12:1029-1039.
147. Mahon JL, Dupre J, Stiller CR. (1993) Lessons learned from use of cyclosporine for insulindependent diabetes mellitus: The case for immunotherapy for insulin-dependent diabetics having residual insulin secretion. Ann NY Acad Sci 696:351-363.
148. Malaisse WJ, Courtois P, Scott FW. (2004) Insulin-dependent diabetes and gut dysfunction: The BB rat model. Horm Metab Res 36:585-594.
149. Malkani S, Nompleggi D, Hansen JW, et al. (1997) Dietary cow’s milk protein does not alter the frequency of diabetes in the BB rat. Diabetes 46:1133-1140.
150. Markees TG, Serreze DV, Phillips NE, et al. (1999) NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes 48:967-974.
151. Markholst H, Klaff LJ, Klöppel G, et al. (1990) Lack of systematically found insulin autoantibodies in spontaneously diabetic BB rats. Diabetes 39:720-727.
152. Martin A-M, Blankenhorn EP, Maxson MN, et al. (1999) Nonmajor histocompatibility complex- linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP BB/Wor rat to the WF rat. Diabetes 48:50-58.
153. Martin A-M, Maxson MN, Leif J, et al. (1999) Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: Additional evidence for a “universal autoimmunity locus” on rat chromosome 4. Diabetes 48:2138-2144.
154. Mathieu C, Kuttler B, Waer M, et al. (1994) Spontaneous reestablishment of self-tolerance in BB/PFD rats. Transplantation 58:349-354.
155. McKeever U, Mordes JP, Greiner DL, et al. (1990) Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc Natl Acad Sci USA 87:7718-7722.
156. McKisic MD, Paturzo FX, Gaertner DJ, et al. (1995) A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. J Immunol 155:3979-3986.
157. Meddings JB, Jarand J, Urbanski SJ, et al. (1999) Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 276:G951-G957.
158. Mendez II, Chung YH, Jun HS, et al. (2004) Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 173:1327-1335.
159. Michalkiewicz M, Michalkiewicz T, Ettinger RA, et al. (2004) Transgenic rescue demonstrates involvement of the Ian5 gene in Tcell development in the rat. Physiol Genom 19:228-232.
160. Moralejo DH, Park HA, Speros SJ, et al. (2003) Genetic dissection of lymphopenia from autoimmunity by introgression of mutated Ian5 gene onto the F344 rat. J Autoimmunity 21:315-324.
161. Mordes J, Flanagan J, Leif J, Greiner D, Kislauskis E, Rossini A, Blankenhorn E, Hillebrands JL, Guberski D. (2003) Autoimmune diabetes in the LEW.1WR1 rat after infection with Kilham rat virus (KRV) or rat cytomegalovirus (RCMV). Diabetes 52 (Suppl 1): A528.
162. Mordes JP, Bortell R, Doukas J, et al. (1996a) The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes/Metab Rev 2:103-109.
163. Mordes JP, Bortell R, Groen H, et al. (2001) Autoimmune diabetes mellitus in the BB rat. In Animal models of diabetes: A primer, ed. Sima AAF, Shafrir E. London: Harwood Academic Publishers, 1-41.
164. Mordes JP, Brown R, Szymanski I, Lundstrom R, Rossini AA. (1986) White blood cell (WBC) transfusion therapy in monozygotic twins discordant for insulin-dependent diabetes mellitus (IDDM). Clin Res 34:550A.
165. Mordes JP, Desemone J, Rossini AA. (1987a) The BB rat. Diabetes/Metab Rev 3:725-750.
166. Mordes JP, Gallina DL, Handler ES, et al. (1987b) Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat. Diabetologia 30:22-26.
167. Mordes JP, Greiner DL, Rossini AA. (2000) Animal models of autoimmune diabetes mellitus. In Diabetes mellitus. A fundamental and clinical text, ed. LeRoith D, Taylor SI, Olefsky JM. New York: Lippincott Williams and Wilkins. 430-441.
168. Mordes JP, Guberski DL, Leif JH, et al. (2005) LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 54:2727-2733.
169. Mordes JP, Leif J, Novak S, et al. (2002) The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 rats. Diabetes 51:3254-3262.
170. Mordes JP, Schirf B, Roipko D, et al. (1996b) Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats. Ann NY Acad Sci 778:418-421.
171. Mordes JP, Serreze DV, Greiner DL, Rossini AA. (2004) Animal models of autoimmune diabetes mellitus. In Diabetes mellitus. A fundamental and clinical text, ed. LeRoith D, Taylor SI, Olefsky JM. New York: Lippincott Williams and Wilkins, 591-610.
172. Mori Y, Suko M, Okudaira H, et al. (1986) Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 29:244-247.
173. Munakata Y, Kodera T, Saito T, et al. (2005) Rheumatoid arthritis, T1D, and Graves’ disease after acute parvovirus B19 infection. Lancet 366:780.
174. Mundinger TO, Mei Q, Figlewicz DP, et al. (2003) Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy. Am J Physiol 285:E1047-E1054.
175. Myers MA, Laks MR, Feeney SJ, et al. (1998) Antibodies to ICA512/IA-2 in rodent models of IDDM. J Autoimmunity 11:265-272.
176. Naji A, Silvers WK, Barker CF. (1983) Bone marrow transplantation in adult diabetes-prone rats. Surg Forum 34:374-376.
177. Najjar SM, Broyart JP, Hampp LT, et al. (2001) Intestinal aminooligopeptidase in diabetic BioBreed rat: Altered posttranslational processing and trafficking. Am J Physiol 280:G104-G112.
178. Nakano K, Mordes JP, Handler ES, et al. (1988) Role of host immune system in BB/Wor rat: Predisposition to diabetes resides in bone marrow. Diabetes 37:520-525.
179. Nepom BS, Nepom GT, Coleman M, et al. (1996) Critical contribution of ß chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc Natl Acad Sci USA 93:7202-7206.
180. Neu J, Reverte CM, Mackey AD, et al. (2005) Changes in intestinal morphology and permeability in the biobreeding rat before the onset of T1D. J Pediat Gastroenterol Nutr 40:589-595.
181. Nicoletti F, Zaccone P, Di Marco R, et al. (1997) Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferongamma antibody. Endocrinology 138:281-288.
182. Nicoletti F, Zaccone P, Di Marco R, et al. (1998) Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats. Diabetes 47:32-38.
183. Norris JM, Barriga K, Klingensmith G, et al. (2003) Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290:1713-1720.
184. Olson DE, Paveglio SA, Huey PU, et al. (2003) Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats. Hum Gene Ther 14:1401-1413.
185. Pandarpurkar M, Wilson-Fritch L, Corvera S, et al. (2003) Ian4 is required for mitochondrial integrity and T cell survival. Proc Natl Acad Sci USA 100:10382-10387.
186. Parving HH, Tarnow L, Nielsen FS, et al. (1999) Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study. Diabetes Care 22:478-483.
187. Payne F, Smyth DJ, Pask R, et al. (2004) Haplotype tag single nucleotide polymorphism analysis of the human orthologues of the rat T1D genes Ian4 (Lyp/Iddm1) and Cblb. Diabetes 53:505-509.
188. Payne F, Smyth DJ, Pask R, et al. (2005) No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with T1D. Biochem Biophys Res Commun 331:435-441.
189. Pearson T, Markees TG, Serreze DV, et al. (2003) Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice. J Immunol 171:185-195.
190. Pearson T, Markees TG, Wicker LS, et al. (2003) NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction. Diabetes 52:321-326.
191. Penhale WJ, Stumbles PA, Huxtable CR, et al. (1990) Induction of diabetes in PVG/c strain rats by manipulation of the immune system. Autoimmunity 7:169-179.
192. Petersen JS, MacKay P, Plesner A, et al. (1997) Treatment with GAD65 or BSA does not protect against diabetes in BB rats. Autoimmunity 25:129-138.
193. Philips JC, Scheen AJ. (2002) Infocongress. Study of the prevention of T1D with nicotinamide: Positive lessons of a negative clinical trial (ENDIT). Rev Med Liege 57:672-675.
194. Pieper GM, Henderson JD, Jr., Roza AM, et al. (2004) A dithiocarbamate analogue decreases intraislet cell infiltration and the incidence of diabetes mellitus in the genetic diabetesprone BB rat. Pancreas 28:E16-E25.
195. Pietropaolo M, Trucco M. (1996) Viral elements in autoimmunity of type I diabetes. Trends Endocrinol Metab 7:139-144.
196. Podlasek CA, Zelner DJ, Harris JD, et al. (2003) Altered sonic hedgehog signaling is associated with morphological abnormalities in the penis of the BB/WOR diabetic rat. Biol Reprod 69:816-827.
197. Popovic J, Kover KL, Moore WV. (2004) The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant BioBreeding rat. Pediat Diabetes 5:3-9.
198. Posselt AM, Barker CF, Friedman AL, et al. (1992) Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256:1321-1324.
199. Poussier P, Nakhooda AF, Falk JF, et al. (1982) Lymphopenia and abnormal lymphocyte subsets in the “BB” rat: Relationship to the diabetic syndrome. Endocrinology 110:1825-1827.
200. Poussier P, Ning T, Murphy T, et al. (2005) Impaired post-thymic development of regulatory CD4+ 25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol 174:4081-4089.
201. Prins J-B, Herberg L, Den Bieman M, Van Zutphen BFM. (1991) Genetic characterization and interrelationship of inbred lines of diabetes-prone and not diabetes-prone BB rats. In Lessons from animal diabetes, ed. Shafrir E. London: Smith-Gordon, 19-24.
202. Qin H-Y, Sadelain MWJ, Hitchon C, et al. (1993) Complete Freund’s adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 150:2072-2080.
203. Rajatanavin R, Appel MC, Reinhardt W, et al. (1991) Variable prevalence of lymphocytic thyroiditis among diabetes-prone sublines of BB/Wor rats. Endocrinology 128:153-157.
204. Ramanathan S, Bihoreau MT, Paterson AD, et al. (2002) Thymectomy and radiation-induced T1D in nonlymphopenic BB rats. Diabetes 51:2975-2981.
205. Ramanathan S, Marandi L, Poussier P. (2002) Evidence for the extrathymic origin of intestinal TCRgammad+ T cells in normal rats and for an impairment of this differentiation pathway in BB rats. J Immunol 168:2182-2187.
206. Ramanathan S, Norwich K, Poussier P. (1998) Antigen activation rescues recent thymic emigrants from programmed cell death in the BB rat. J Immunol 160:5757-5764.
207. Ramanathan S, Poussier P. (1999) T cell reconstitution of BB/W rats after the initiation of insulitis precipitates the onset of diabetes. J Immunol 162:5134-5142.
208. Ramanathan S, Poussier P. (2001) BB rat lyp mutation and T1D. Immunol Rev 184:161-171.
209. Rasmussen SB, Sorensen TS, Hansen JB, et al. (2000) Functional rest through intensive treatment with insulin and potassium channel openers preserves residual ß-cell function and mass in acutely diabetic BB rats. Horm Metab Res 32:294-300.
210. Redondo MJ, Yu L, Hawa M, et al. (2001) Heterogeneity of type I diabetes: Analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354-362.
211. Reimers JI, Andersen HU, Mauricio D, et al. (1996) Strain-dependent differences in sensitivity of rat ß-cells to interleukin 1ß in vitro and in vivo-Association with islet nitric oxide synthesis. Diabetes 45:771-778.
212. Rodier M, Ribstein J, Parer-Richard C, et al. (1991) Renal changes associated with cyclosporine in recent type I diabetes mellitus. Hypertension 18:334-340.
213. Roep BO, Atkinson M. (2004) Animal models have little to teach us about T1D: 1. In support of this proposal. Diabetologia 47:1650-1656.
214. Rossini AA. (2004) From beast to bedside: A commentary. Diabetologia 47:1647-1649.
215. Rossini AA, Mordes JP, Pelletier AM, et al. (1983) Transfusions of whole blood prevent spontaneous diabetes in the BB/W rat. Science 219:975-977.
216. Sadelain MW, Qin HY, Sumoski W, et al. (1990) Prevention of diabetes in the BB rat by early immunotherapy using Freund’s adjuvant. J Autoimmunity 3:671-680.
217. Satoh J, Seino H, Shintani S, et al. (1990) Inhibition of T1D in BB rats with recombinant human tumor necrosis factor-a. J Immunol 145:1395-1399.
218. Satoh J, Shintani S, Oya K, et al. (1988) Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 37:1188-1194.
219. Schmidt RE, Dorsey DA, Beaudet LN, et al. (2004) Experimental rat models of types 1 and diabetes differ in sympathetic neuroaxonal dystrophy. J Neuropath Exp Neurol 63:450-460.
220. Schröder D, Ratke M, Bauer UC, et al. (2002) Prophylactic insulin treatment of DP BB/OK rats by application of a sustained release insulin implant. Autoimmunity 35:143-153.
221. Scott FW, Cloutier HE, Kleemann R, et al. (1997) Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats. Dose, timing, early effect on islet area, switch in infiltrate from Th1 to Th2 cells. Diabetes 46:589-598.
222. Scott FW, Marliss EB. (1991) Conference summary: Diet as an environmental factor in development of insulin-dependent diabetes. Can J Physiol Pharmacol 69:311-319.
223. Scott FW, Rowsell P, Wang GS, et al. (2002) Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 51:73-78.
224. Serreze DV, Leiter EH. (2001) Genes and pathways underlying autoimmune diabetes in NOD mice. In Molecular pathology of insulin-dependent diabetes mellitus, ed. Von Herrath MG. Geneva: Karger Press, 3:1-67.
225. Sigfrid LA, Cunningham JM, Beeharry N, et al. (2004) Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of T1D and an insulin-producing cell line. J Mol Med 82:325-335.
226. Simons PJ, Delemarre FG, Jeucken PH, et al. (1998) Preautoimmune thyroid abnormalities in the biobreeding diabetes-prone (BB-DP) rat: A possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. J Endocrinol 157:43-51.
227. Simonson W, Ramanathan S, Bieg S, et al. (2002) Protein-free diets do not protect highincidence diabetes-prone BioBreeding rats from diabetes. Metabolism 51:569-574.
228. Skyler JS, Brown D, Chase HP, et al. (2002) Effects of insulin in relatives of patients with T1D mellitus. N Engl J Med 346:1685-1691.
229. Skyler JS, Krischer JP, Wolfsdorf J, et al. (2005) Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diab Care 28:1068-1076.
230. Sobel DO, Azumi N, Creswell K, et al. (1995) The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes-prone BB rat. J Autoimmunity 8:843-857.
231. Sobel DO, Creswell K, Yoon JW, et al. (1998) Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats. Life Sci 62:1293-1302.
232. Sobel DO, Ewel CH, Zeligs B, et al. (1994) Poly I:C induction of a-interferon in the diabetesprone BB and normal Wistar rats: Dose-response relationships. Diabetes 43:518-522.
233. Sobel DO, Goyal D, Ahvazi B, et al. (1998) Low-dose poly I:C prevents diabetes in the diabetes prone BB rat. J Autoimmunity 11:343-352.
234. Sobel DO, Newsome J. (1997) Gamma interferon prevents diabetes in the BB rat. Clin Diag Lab Immunol 4:764-768.
235. Sobel DO, Newsome J, Ewel CH, et al. (1992) Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 41:515-520.
236. Sommandas V, Rutledge EA, Van Yserloo B, et al. (2005a) Aberrancies in the differentiation and maturation of dendritic cells from bone-marrow precursors are linked to various genes on chromosome 4 and other chromosomes of the BB-DP rat. J Autoimmunity 25:1-12.
237. Sommandas V, Rutledge EA, Van Yserloo B, et al. (2005b) Defects in differentiation of bonemarrow derived dendritic cells of the BB rat are partly associated with IDDM2 (the lyp gene) and partly associated with other genes in the BB rat background. J Autoimmunity 25:46-56.
238. Song HY, Abad MM, Mahoney CP, et al. (1999) Human insulin B chain but not A chain decreases the rate of diabetes in BB rats. Diabetes Res Clin Pract 46:109-114.
239. Sparre T, Christensen UB, Gotfredsen CF, et al. (2004) Changes in expression of IL-1ß influenced proteins in transplanted islets during development of diabetes in diabetesprone BB rats. Diabetologia 47:892-908.
240. Stevens MJ, Zhang W, Li F, et al. (2004) C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol 287:E497-E505.
241. Stumbles PA and Penhale WJ. (1993) IDDM in rats induced by thymectomy and irradiation. Diabetes 42:571-578.
242. Tafuri A, Bowers WE, Handler ES, et al. (1993) High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors. J Clin Invest 91:2040-2048.
243. Takahashi K, Satoh J, Seino H, et al. (1993) Prevention of type I diabetes with lymphotoxin in BB rats. Clin Immunol Immunopathol 69:318-323.
244. Thomas VA, Woda BA, Handler ES, et al. (1991) Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes 40:255-258.
245. Tirabassi RS, Flanagan JF, Wu T, et al. (2004) The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus. ILAR J 45:292-302.
246. Tirabassi RS, Guberski DL, Leif JH, Winans DA, Mordes JP. (2005) Maternal immunization protects weanling LEW.1WR1 rats from cytomegalovirus-induced diabetes. Diabetes 54 (Suppl 1):A94.
247. Todd DJ, Forsberg EM, Greiner DL, et al. (2004) Deficiencies in gut NK cell number and function precede diabetes onset in BB rats. J Immunol 172:5356-5362.
248. Todd JA. (1999) From genome to aetiology in a multifactorial disease, T1D. BioEssays 21:164-174.
249. Tori M, Ito T, Yumiba T, et al. (1999) Significant role of intragraft lymphoid tissues in preventing insulin-dependent diabetes mellitus recurrence in whole pancreaticoduodenal transplantation. Microsurgery 19:338-343.
250. Trudeau JD, Dutz JP, Arany E, et al. (2000) Neonatal ß-cell apoptosis-A trigger for autoimmune diabetes? Diabetes 49:1-7.
251. Tulic MK, Fiset PO, Manoukian JJ, et al. (2004) Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 363:1689-1697.
252. Van den Brandt J, Kovács P, Klöting I. (1999) Congenic diabetes-prone BB.Sa and BB.Xs rats differ from their progenitor strain BB/OK in frequency and severity of insulindependent diabetes mellitus. Biochem Biophys Res Commun 263:843-847.
253. van der Werf N, Hillebrands JL, Klatter FA, et al. (2003) Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin Dev Immunol 10:153-160.
254. Villanueva DS, Poirier P, Standley PR, et al. (2003) Prevention of ischemic heart failure by exercise in spontaneously diabetic BB Wor rats subjected to insulin withdrawal. Metabolism 52:791-797.
255. Visalli N, Sebastiani L, Adorisio E, et al. (2003) Environmental risk factors for T1D in Rome and province. Arch Dis Child 88:695-698.
256. Visser J, Groen H, Klatter F, et al. (2002) Timing of pentoxifylline treatment determines its protective effect on diabetes development in the BioBreeding rat. Eur J Pharmacol 445:133-140.
257. Visser J, Groen H, Klatter F, et al. (2003) The diabetes-prone BB rat model of IDDM shows duration of breastfeeding to influence T1D development later in life. Diabetologia 46:1711-1713.
258. Visser J, Klatter F, Vis L, et al. (2003) Long-term prophylactic insulin treatment can prevent spontaneous diabetes and thyroiditis development in the diabetes-prone BioBreeding rat, while short-term treatment is ineffective. Eur J Endocrinol 149:223-229.
259. Von Herrath MG, Fujinami RS, Whitton JL. (2003) Microorganisms and autoimmunity: Making the barren field fertile? Nat Rev Microbiol 1:151-157.
260. Wang GS, Gruber H, Smyth P, et al. (2000) Hydrolyzed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. J Autoimmunity 15:407-416.
261. Wang GS, Rosenberg L, Scott FW. (2005) Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab Invest 85:675-688.
262. Watson WC, Thompson JP, Terato K, et al. (1990) Human HLA-DRß gene hypervariable region homology in the biobreeding BB rat: Selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen. J Exp Med 172:1331-1339.
263. Wedekind D, Weiss H, Jörns A, et al. (2005) Effects of polyinosinic-polycytidylic acid and adoptive transfer of immune cells in the Lew.1AR1-iddm rat and in its coisogenic LEW.1AR1 background strain. Autoimmunity 38:265-275.
264. Weiss H, Bleich A, Hedrich HJ, et al. (2005) Genetic analysis of the LEW.1AR1-iddm rat: An animal model for spontaneous diabetes mellitus. Mamm Genome 16:432-441.
265. Whalen BJ, Mordes JP, Rossini AA. (1996) The BB rat as a model of human insulin-dependent diabetes mellitus. In Animal models for autoimmune and inflammatory disease, ed. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. New York: John Wiley & Sons, 15.3.1-15.3.15.
266. Wilkin T, Kiesel U, Diaz J-L, et al. (1986) Autoantibodies to insulin as serum markers for autoimmune insulitis. Diabetes Res 3:173-174.
267. Woda BA, Like AA, Padden C, et al. (1986) Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol 136:856-859.
268. Yagi H, Matsumoto M, Suzuki S, et al. (1991) Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice. Cell Immunol 138:130-141.
269. Yale J-F, Grose M, Marliss EB. (1985) Time course of the lymphopenia in BB rats. Relation to the onset of diabetes. Diabetes 34:955-959.
270. Ye XJ, Tang B, Ma Z, et al. (2004) The roles of interleukin-18 in collagen-induced arthritis in the BB rat. Clin Exp Immunol 136:440-447.
271. Yokoi N. (2005) Identification of a major gene responsible for T1D in the Komeda diabetesprone rat. Exp Anim 54:111-115.
272. Yokoi N, Kanazawa M, Kitada K, et al. (1997) A non-MHC locus essential for autoimmune type I diabetes in the Komeda diabetes-prone rat. J Clin Invest 100:2015-2021.
273. Yokoi N, Komeda K, Wang HY, et al. (2002) Cblb is a major susceptibility gene for rat T1D mellitus. Nat Genet 31:391-394.
274. Yoon J-W, Jun H-S. (2004) Role of viruses in the pathogenesis of type 1 diabetes mellitus. In Diabetes mellitus. A fundamental and clinical text, ed. LeRoith D, Taylor SI, Olefsky JM. New York: Lippincott Williams & Wilkins, 575-590.
275. Zenz R, Eferl R, Kenner L, et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369-375.
276. Zhang ZJ, Davidson L, Eisenbarth G, et al. (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256.
277. Ziegler M, Schlosser M, Hamann J, et al. (1994) Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes. Exp Clin Endocrinol 102:98-103.
278. Zipris D, Greiner DL, Malkani S, et al. (1996) Cytokine gene expression in islets and thyroids of BB rats: Interferon gamma and IL-12 p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 156:1315-1321.
279. Zipris D, Hillebrands JL, Welsh RM, et al. (2003) Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J Immunol 170:3592-3602.
280. Zipris D, Karnieli E. (2002) A single treatment with IL-4 via retrovirally transduced lymphocytes partially protects against diabetes in BioBreeding (BB) rats. JOP 3:76-82.
281. Zipris D, Lien E, Xie JX, et al. (2005) TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 174:131-142.